Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Edwin Singer, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Daniel Singer and Jeffrey Ashburner.
Daniel Singer
Connection Strength
4.124
Jeffrey Ashburner
  1. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. J Am Geriatr Soc. 2017 01; 65(1):35-41.
    View in: PubMed
    Score: 0.685
  2. Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence. J Am Coll Cardiol. 2016 05 17; 67(19):2319.
    View in: PubMed
    Score: 0.663
  3. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. J Am Coll Cardiol. 2016 Jan 26; 67(3):239-47.
    View in: PubMed
    Score: 0.649
  4. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). Am J Cardiol. 2015 Jan 01; 115(1):40-6.
    View in: PubMed
    Score: 0.593
  5. Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial. Circulation. 2022 Mar 29; 145(13):946-954.
    View in: PubMed
    Score: 0.247
  6. Re-CHARGE-AF: Recalibration of the CHARGE-AF Model for Atrial Fibrillation Risk Prediction in Patients With Acute Stroke. J Am Heart Assoc. 2021 11 02; 10(21):e022363.
    View in: PubMed
    Score: 0.241
  7. Point-of-care screening for atrial fibrillation: Where are we, and where do we go next? Cardiovasc Digit Health J. 2021 Dec; 2(6):294-297.
    View in: PubMed
    Score: 0.241
  8. Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial. Am Heart J. 2019 09; 215:147-156.
    View in: PubMed
    Score: 0.205
  9. Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial. J Gen Intern Med. 2018 12; 33(12):2070-2077.
    View in: PubMed
    Score: 0.193
  10. Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants. Am J Cardiol. 2017 Sep 01; 120(5):786-791.
    View in: PubMed
    Score: 0.179
  11. Comparative Clinical Effectiveness of Population-Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision-Analytic Model. J Am Heart Assoc. 2021 09 21; 10(18):e020330.
    View in: PubMed
    Score: 0.060
  12. Usefulness of Rhythm Monitoring Following Acute Ischemic Stroke. Am J Cardiol. 2021 05 15; 147:44-51.
    View in: PubMed
    Score: 0.058
  13. Automated Electronic Phenotyping of Cardioembolic Stroke. Stroke. 2021 01; 52(1):181-189.
    View in: PubMed
    Score: 0.057
  14. Initial Precipitants and Recurrence of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2020 03; 13(3):e007716.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.